ASSERTIO HOLDINGS, INC. Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2024-01-01: Study NCT06083571; Company role Collaborator; Phase Phase 2; Status Terminated.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2024-01-01 | NCT06083571 Intranasal Ketorolac Trial | Collaborator Lead: Washington University School of Medicine | Phase 2 | Terminated | Headache, Migraine | 41 | 2025-12-31 |